VeriMomartemisia annua extract est-il sûr pendant la grossesse ?
Artemisia annua extracts can contain artemisinin-class compounds, which produce severe embryotoxicity and developmental effects in multiple animal species; WHO and systematic reviews cite animal embryotoxicity/teratogenicity for artemisinin derivatives and advise caution in early pregnancy. There is no EU Annex II/III ban or harmonised CLP for the botanical extract itself, but the demonstrated animal reproductive toxicity of artemisinin (a likely component) justifies a 'suspected' reproductive hazard. (Sources: WHO nonclinical overview; systematic reviews and PubMed reviews).
Alternatives sûres à artemisia annua extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- artemisia annua extract est-il sûr pendant la grossesse ?
- Artemisia annua extracts can contain artemisinin-class compounds, which produce severe embryotoxicity and developmental effects in multiple animal species; WHO and systematic reviews cite animal embryotoxicity/teratogenicity for artemisinin derivatives and advise caution in early pregnancy. There is no EU Annex II/III ban or harmonised CLP for the botanical extract itself, but the demonstrated animal reproductive toxicity of artemisinin (a likely component) justifies a 'suspected' reproductive hazard. (Sources: WHO nonclinical overview; systematic reviews and PubMed reviews).
- artemisia annua extract est-il sûr pendant l'allaitement ?
- Direct data on transfer of Artemisia annua extract or artemisinin into human milk are limited. Given the known animal embryo/foetal effects for artemisinin derivatives, a theoretical/class-based concern exists for breastfeeding exposure (precautionary), but there is insufficient direct evidence of harm via breastmilk in humans. Exposure from topical cosmetic use is expected to be low but measurable. (Sources: WHO review; clinical reviews summarising limited human/breastfeeding data).
- artemisia annua extract est-il sûr pour la peau de bébé ?
- No infant-specific safety studies for topical Artemisia annua extract were found. Because the extract may contain artemisinin-class molecules that have demonstrated systemic embryotoxic mechanisms (affecting primitive erythroblasts and angiogenesis) and because infant skin has higher absorption per kg, the hazard and mechanistic concern are carried over from adult data (h=2, m=2) while exposure is increased by one category for infants (e increased). There is no evidence (e.g., harmonised CLP or EU ban) specific to cosmetic topical use to lower this concern. (Sources: WHO, systematic reviews, CosIng/EU listings, EWG).
- Comment VeriMom évalue-t-il artemisia annua extract ?
- VeriMom évalue artemisia annua extract à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à artemisia annua extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à artemisia annua extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.